842 related articles for article (PubMed ID: 18651694)
41. Purification and biochemical characterization of Mur ligases from Staphylococcus aureus.
Patin D; Boniface A; Kovač A; Hervé M; Dementin S; Barreteau H; Mengin-Lecreulx D; Blanot D
Biochimie; 2010 Dec; 92(12):1793-800. PubMed ID: 20659527
[TBL] [Abstract][Full Text] [Related]
42. Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship.
Hrast M; Frlan R; Knez D; Zdovc I; Barreteau H; Gobec S
Bioorg Med Chem Lett; 2021 May; 40():127966. PubMed ID: 33744441
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of some classical hydrazones of ketones and 1,2-diketones as antileishmanial, antibacterial and antifungal agents.
Al-Kahraman YM; Yasinzai M; Singh GS
Arch Pharm Res; 2012 Jun; 35(6):1009-13. PubMed ID: 22870810
[TBL] [Abstract][Full Text] [Related]
44. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
[TBL] [Abstract][Full Text] [Related]
45. MurD enzymes from different bacteria: evaluation of inhibitors.
Barreteau H; Sosič I; Turk S; Humljan J; Tomašić T; Zidar N; Hervé M; Boniface A; Peterlin-Mašič L; Kikelj D; Mengin-Lecreulx D; Gobec S; Blanot D
Biochem Pharmacol; 2012 Sep; 84(5):625-32. PubMed ID: 22705647
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents.
Bekhit AA; Fahmy HT; Rostom SA; El-Din A Bekhit A
Eur J Med Chem; 2010 Dec; 45(12):6027-38. PubMed ID: 20970223
[TBL] [Abstract][Full Text] [Related]
47. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
[TBL] [Abstract][Full Text] [Related]
48. Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductase.
Gilbert AM; Failli A; Shumsky J; Yang Y; Severin A; Singh G; Hu W; Keeney D; Petersen PJ; Katz AH
J Med Chem; 2006 Oct; 49(20):6027-36. PubMed ID: 17004716
[TBL] [Abstract][Full Text] [Related]
49. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
[TBL] [Abstract][Full Text] [Related]
50. Structure of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC).
Deva T; Baker EN; Squire CJ; Smith CA
Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1466-74. PubMed ID: 17139082
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of aminoketones.
Sankappa Rai U; Isloor AM; Shetty P; Isloor N; Malladi S; Fun HK
Eur J Med Chem; 2010 Dec; 45(12):6090-4. PubMed ID: 20889241
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
[TBL] [Abstract][Full Text] [Related]
53. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
Chhajed SS; Upasani CD
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
[TBL] [Abstract][Full Text] [Related]
55. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity.
Deshmukh MB; Salunkhe SM; Patil DR; Anbhule PV
Eur J Med Chem; 2009 Jun; 44(6):2651-4. PubMed ID: 19036478
[TBL] [Abstract][Full Text] [Related]
56. 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures.
Sriram D; Yogeeswari P; Vyas DR; Senthilkumar P; Bhat P; Srividya M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4313-6. PubMed ID: 20615698
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and activity study of phosphonamidate dipeptides as potential inhibitors of VanX.
Yang KW; Cheng X; Zhao C; Liu CC; Jia C; Feng L; Xiao JM; Zhou LS; Gao HZ; Yang X; Zhai L
Bioorg Med Chem Lett; 2011 Dec; 21(23):7224-7. PubMed ID: 22001030
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and preliminary antibacterial evaluation of 2-butyl succinate-based hydroxamate derivatives containing isoxazole rings.
Zhang D; Jia J; Meng L; Xu W; Tang L; Wang J
Arch Pharm Res; 2010 Jun; 33(6):831-42. PubMed ID: 20607487
[TBL] [Abstract][Full Text] [Related]
59. Antibacterial activity, structure and CMC relationships of alkanediyl alpha,omega-bis(dimethylammonium bromide) surfactants.
Laatiris A; El Achouri M; Infante MR; Bensouda Y
Microbiol Res; 2008; 163(6):645-50. PubMed ID: 17207986
[TBL] [Abstract][Full Text] [Related]
60. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
